Trimodal therapy with high-dose-rate brachytherapy and hypofractionated external beam radiation combined with long-term androgen deprivation for unfavorable-risk prostate cancer.
Mori K, Sasaki H, Tsutsumi Y, Sato S, Takiguchi Y, Saito S, Nishi E, Ishii G, Yamamoto T, Koike Y, Miki J, Shimomura T, Kimura T, Miki K, Shariat SF, Takahashi H, Aoki M, Egawa S.
Mori K, et al. Among authors: yamamoto t.
Strahlenther Onkol. 2021 Nov;197(11):976-985. doi: 10.1007/s00066-021-01784-3. Epub 2021 Apr 28.
Strahlenther Onkol. 2021.
PMID: 33909100
Free PMC article.